You just read:

Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

News provided by

Allergan plc , Editas Medicine, Inc.

Mar 14, 2017, 08:00 ET